Lung Cancer & COVID Infection
Trial Objectives
Researchers want to understand how the body of a person with active lung cancer responds to COVID-19, should they contract the virus. Volunteers do not need to be vaccinated or to have an active case of COVID to participate. Study participants will be required to provide a blood sample and their medical history.
Who Can Participate
Adults with an active diagnosis of lung cancer.
Age: 18+ Gender: Any
Estimated Time Commitment
Up to 24 months. In-person study visits occurring at enrollment and at these monthly intervals- 3, 6, 9, 12, 15, 18, 21 and 24 months.
Payment & Reimbursement
Payment: Not Provided
Travel Reimbursement: Not Available
Trial Contact
For more information, contact:
Daniell Plomondon
303-270-2041
Trial Location
National Jewish Main Campus, Denver, CO
Trial Sponsors
National Cancer Institute
Payments are intended to compensate the participant for their time and effort during the study. Payments are typically given to the participant at the end of each completed study visit.
Reimbursements are intended to compensate the participant for travel-related expenses. They must be approved by the study staff and require you to turn in receipts. Travel reimbursement will vary from study to study.
Principal Investigators
Jeffrey Kern, MD
Co-Investigators
-
Laurie L. Carr, MD
-
Ellen Volker, MD, MSPH
Request more Information
By completing this form, you agree to learn more about this study and see if you qualify.